CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · IEX Real-Time Price · USD
0.362
-0.007 (-1.84%)
At close: Mar 28, 2024, 4:00 PM
0.392
+0.030 (8.29%)
After-hours: Mar 28, 2024, 7:30 PM EDT

CNS Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Cash & Equivalents
10.06514.047.240.56
Cash & Cash Equivalents
10.06514.047.240.56
Cash Growth
100.93%-64.35%93.88%1204.42%-
Other Current Assets
2.512.471.460.650.03
Total Current Assets
12.567.4815.57.890.59
Property, Plant & Equipment
0.010.020.020.020
Other Long-Term Assets
0.481.260.3300.1
Total Long-Term Assets
0.491.280.360.020.1
Total Assets
13.058.7615.857.910.68
Accounts Payable
4.511.980.950.290.13
Current Debt
0.410.390.4400.32
Other Current Liabilities
00.220.520.020.79
Total Current Liabilities
4.922.591.910.311.23
Total Liabilities
4.922.591.910.311.23
Total Debt
0.410.390.4400.32
Debt Growth
5.72%-11.72%---
Retained Earnings
-50.72-35.44-20.95-11.49-7.61
Shareholders' Equity
8.136.1613.957.6-0.55
Net Cash / Debt
9.654.6213.67.240.24
Net Cash / Debt Growth
108.92%-66.05%87.81%2939.81%-
Net Cash Per Share
7.085.2624.5515.920.68
Working Capital
7.644.8813.597.58-0.64
Book Value Per Share
5.977.0225.1816.71-1.57
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).